Kevin DeKeter
Equity research analyst · Ladenburg Thalmann
Earnings calls
1
Nov 4, 2026 – Nov 4, 2026
Stocks asked about
1
Questions
1
Firm rating actions
0
on these stocks, from news
Coverage
Companies whose earnings calls Kevin DeKeter asked questions on (from Lician's transcripts).
Questions on earnings calls
- URGN earnings call · UroGen Pharma Ltd.Nov 4, 2026 · 1 question
- 55:19
“Maybe just three quick ones with regard to Sudari kind of commercial metrics. One, can you kind of comment from an operational perspective, what part of the commercial team's messaging is most effective in terms of the marketing? You need first-time users to repeat users. And…”
- 55:19
Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.
Ladenburg Thalmann rating actions on these stocks
From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Kevin DeKeter. We do not use licensed rating databases.
No rating action by Ladenburg Thalmann on these stocks in the headlines we store yet.